Business Context and Reporting Period
This Form 8-K Current Report is filed by Integrity Applications, Inc. (not Glucotrack, Inc.) for the period ending March 23, 2016. The report details corporate governance changes, specifically the appointment of new directors and the establishment of a new board committee.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on governance and compensation arrangements.
Material Changes
- Board Expansion: The Board of Directors increased in size from four to five members.
- Director Appointments: Leslie Seff and Angela Strand were appointed as directors, effective March 23, 2016, following the resignation of Zvi Cohen.
- Committee Formation: A Nominating and Corporate Governance Committee was established, with Angela Strand appointed as chairperson.
- Compensation Plan Amendment: The 2010 Incentive Compensation Plan was amended to increase the share reserve from 529,555 to 1,000,000 shares.
Guidance, Outlook, and Compensation Details
The filing outlines new compensatory arrangements for non-employee directors approved on March 17, 2016:
- Cash Compensation: An annual payment of $15,000 per director, payable in quarterly installments of $3,750 starting in Q2 2016.
- Committee Chair Fee: An additional annual payment of $10,000 for the chairperson of the Nominating and Corporate Governance Committee, payable in quarterly installments of $2,500.
- Stock Options: A one-time grant of options to purchase an aggregate of 26,666 shares of Common Stock at an exercise price of $4.50 per share was approved for Dr. Fischell, Mr. Seff, and Ms. Strand. These options vest in eight equal quarterly increments.
The filing states there are no undisclosed relationships or arrangements regarding the selection of the new directors.
Investor Verification Checklist
- Verify the full text of the letter agreements (Exhibits 10.1 and 10.2) for specific terms regarding the new directors.
- Review the full text of Amendment No. 1 to the 2010 Incentive Compensation Plan (Exhibit 10.3) to understand the impact of the increased share reserve.
- Confirm the vesting schedule and exercise conditions for the 26,666 option grants.
- Note that this filing contains no financial results; refer to the most recent 10-K or 10-Q for financial performance data.